The relationship between the quantitative evaluation of thyroid bed uptake and the disappearance of accumulation in adjuvant radioactive iodine therapy for differentiated thyroid cancer

被引:8
|
作者
Konishi, Kenta [1 ]
Ishiba, Ryo [1 ]
Ikenohira, Tsutomu [1 ]
Asao, Tomoyuki [1 ]
Hirata, Masanori [1 ]
Ohira, Keiichi [1 ]
Komatsu, Tetsuya [1 ]
Sawada, Michifumi [2 ]
Tanahashi, Yukichi [3 ]
Goshima, Satoshi [3 ]
Magata, Yasuhiro [4 ]
Nakamura, Katsumasa [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Radiat Oncol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka, Japan
[2] Hamamatsu Univ Sch Med, Dept Radiol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka, Japan
[3] Hamamatsu Univ Sch Med, Dept Diagnost Radiol & Nucl Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ Sch Med, Preeminent Med Photon Educ & Res Ctr, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka, Japan
关键词
Thyroid cancer; Radioactive iodine therapy; Adjuvant therapy; Quantitative evaluation; Absolute radioactivity concentration; CARCINOMA; ABLATION;
D O I
10.1007/s12149-020-01546-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Iodine-131 (I-131) radioactive iodine therapy (RAI) after total thyroidectomy is the standard treatment for patients with differentiated thyroid cancer (DTC). We investigated the relationship between the quantitative parameters of the iodine uptake and the disappearance of the accumulation in the thyroid bed in adjuvant therapy using a 1.11 GBq or 3.70 GBq dose of I-131. Methods We retrospectively analyzed the cases of 40 patients with DTC who were treated with RAI at our institution between April 2017 and August 2019. The patients were treated with the I-131 dose of 1.11 GBq (n = 25) or 3.70 GBq (n = 15) after total thyroidectomy. The I-131 whole-body scan and hybrid single-photon emission computed tomography/X-ray computed tomography (SPECT/CT) were performed 3 days after RAI. Using image analysis software, we measured the standardized uptake value (SUV) and absolute radioactivity concentration (kBq/ml) on the target lesions with the highest uptake in the thyroid bed. Results The median period from RAI to the evaluation of the absence of uptake of the thyroid bed was 6.75 months. After RAI, uptake of the thyroid bed disappeared in 26 of the 40 patients. The disappearance rate was significantly higher in the 3.70 GBq group than in the 1.11 GBq group (86.7% vs. 52.0%, respectively; p = 0.029). However, there were no significant differences in the values of kBq/ml or SUV between the 1.11 GBq group and 3.70 GBq group. On the other hand, the group in which the uptake disappeared after RAI showed significantly higher kBq/ml max and kBq/ml mean values than the group in which the uptake did not disappear after RAI (p = 0.028, p = 0.032, respectively). The SUVmax and SUVmean also tended to be higher in the disappeared-uptake group than the not-disappeared-uptake group, but the differences were not significant (p = 0.166, p = 0.176, respectively). Conclusions The quantitative evaluation might be useful as one of the predictive indicators of the disappearance of the accumulation of radioactive iodine in the thyroid bed.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 50 条
  • [31] Radioactive iodine in differentiated thyroid cancer: a national database perspective
    Orosco, Ryan K.
    Hussain, Timon
    Noel, Julia E.
    Chang, David C.
    Dosiou, Chrysoula
    Mittra, Erik
    Divi, Vasu
    Orloff, Lisa A.
    ENDOCRINE-RELATED CANCER, 2019, 26 (10) : 795 - 802
  • [32] Radioactive Iodine-Refractory Differentiated Thyroid Cancer in the Elderly
    Gosain, Rohit
    Alexander, Jonathan S.
    Gill, Amitoj
    Perez, Cesar
    CURRENT ONCOLOGY REPORTS, 2018, 20 (10)
  • [33] Postoperative radioactive iodine administration for differentiated thyroid cancer patients
    Lepoutre-Lussey, Charlotte
    Deandreis, Desiree
    Leboulleux, Sophie
    Schlumberger, Martin
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (05) : 363 - 371
  • [34] Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer
    An, Jee Hyun
    Song, Kee-Ho
    Kim, Dong-Lim
    Kim, Suk Kyeong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2017, 45 (01) : 38 - 50
  • [35] Preparation for radioactive iodine administration in differentiated thyroid cancer patients
    Liel, Y
    CLINICAL ENDOCRINOLOGY, 2002, 57 (04) : 523 - 527
  • [36] Radioactive Iodine-Refractory Differentiated Thyroid Cancer in the Elderly
    Rohit Gosain
    Jonathan S. Alexander
    Amitoj Gill
    Cesar Perez
    Current Oncology Reports, 2018, 20
  • [37] Chapter 7: Radioactive Iodine Treatment in Differentiated Thyroid Cancer
    Agrawal, Archi
    Dhar, Harsh
    JOURNAL OF HEAD & NECK PHYSICIANS AND SURGEONS, 2024, 12 (SUPPL 1): : S36 - S42
  • [38] Overview of Radioactive Iodine-Resistant Differentiated Thyroid Cancer
    Sherman, Steven I.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (07) : 3 - 5
  • [39] Early Sialadenitis After Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Prevalence and Predictors
    Riachy, Ruba
    Ghazal, Nisrine
    Haidar, Mohamad B.
    Elamine, Ahmad
    Nasrallah, Mona P.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2020, 2020
  • [40] Surgical approach and radioactive iodine therapy for small well-differentiated thyroid cancer
    Momesso, D. P.
    Vaisman, F.
    Caminha, L. S. C.
    Pessoa, C. H. C. N.
    Corbo, R.
    Vaisman, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (01) : 57 - 64